Disappointing End For MolMed’s Zalmoxis Cell Therapy In EU

Real World Data Played A Key Role In The Drug’s Initial Approval

 
• By Vibha Sharma
  
Clinical trial
Zalmoxis Failed To Meet Its Primary Endpoint • Source: Shutterstock

More from Europe

More from Geography